GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Wiley  (3)
  • Baillet, Marion  (3)
  • 1
    In: Alzheimer's & Dementia, Wiley, Vol. 17, No. 3 ( 2021-03), p. 407-416
    Abstract: We searched for consistent associations of an omega‐3 index in plasma (sum of eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA] ) with several dementia‐related outcomes in a large cohort of older adults. Methods We included 1279 participants from the Three‐City study, non‐demented at the time of blood measurements at baseline, with face‐to‐face neuropsychological assessment and systematic detection of incident dementia over a 17‐year follow‐up. An ancillary study included 467 participants with up to three repeated brain imaging exams over 10 years. Results In multivariable models, higher levels of plasma EPA+DHA were consistently associated with a lower risk of dementia (hazard ratio for 1 standard deviation = 0.87 [95% confidence interval, 0.76–0.98]), and a lower decline in global cognition ( P  = .04 for change over time), memory ( P  = .06), and medial temporal lobe volume ( P  = .02). Discussion This prospective study provides compelling evidence for a relationship between long‐chain omega‐3 fatty acids levels and lower risks for dementia and related outcomes.
    Type of Medium: Online Resource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2201940-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Alzheimer's & Dementia, Wiley, Vol. 16, No. S10 ( 2020-12)
    Abstract: Long‐chain omega‐3 polyunsaturated fatty acids (n‐3 PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), mainly provided together by fish intake in the human diet, are important constituents of neural membranes. Epidemiological studies reported associations between long‐chain n‐3 PUFA intakes or blood concentrations, and lower risks of dementia and related outcomes (cognitive decline, brain atrophy). However, evidence has been inconsistent according to the type (e.g., EPA, DHA or total n‐3 PUFA) and/or the exposures (intake versus blood status) investigated. Moreover, previous studies displayed short follow‐up periods (generally less than 5 years). In this study, we took advantage of the long follow‐up for dementia and related outcomes in a large cohort of older persons, the Three‐City (3C) study, to look for robust associations of an omega‐3 index in plasma (EPA+DHA), with the long‐term evolution of three complementary outcomes: atrophy of the medial temporal lobe (MTL, a biomarker of dementia), cognitive decline and incidence of dementia. Method We included 1279 participants (aged ≥65) from the 3C study, non‐demented at the time of blood measurements at baseline. Face‐to‐face neuropsychological assessments at baseline and follow‐up visits (7 visits over 17 years) were used to evaluate global cognitive decline (n=1185), memory decline (n=1039), and for the systematic detection of incident dementia. An ancillary study included 467 participants with up to three repeated brain imaging exams over 10 years (FreeSurfer 5.1 segmentation). Linear mixed models were used to assess the associations between plasma EPA+DHA and trajectories of global cognition, memory and MTL volumes. The association between EPA+DHA and the risk of dementia was estimated by a Cox model. Result Higher levels of plasma EPA+DHA were associated with a lower risk of dementia (HR for 1SD = 0.87 [95% CI, 0.76‐0.98]), and a lower decline in global cognition ( P = .04 for change over time), memory ( P = .06) and MTL volume ( P = .02). Conclusion The consistency of the long‐term associations found between higher levels of plasma EPA+DHA and three dementia related outcomes in this large cohort of older adults provides compelling evidence for the interest of long‐chain n‐3 PUFA in dementia and cognitive decline prevention.
    Type of Medium: Online Resource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2201940-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Alzheimer's & Dementia, Wiley, Vol. 16, No. S10 ( 2020-12)
    Abstract: Carotenoids are vegetable pigments uniquely provided by diet which have antioxidant, immunomodulatory and specific neuroprotective properties. Carotenes (found in orange‐yellow fruits and vegetables) are precursors of retinoids, key signaling molecules for synaptic plasticity. The xanthophylls, lutein and zeaxanthin (found in green vegetables, orange‐yellow fruits and corn) cross the blood‐brain barrier, may decrease lipid peroxidation and stabilize lipid‐protein structures in neuronal membranes. Limited epidemiological studies on dietary carotenoids (assessed by questionnaires) reported inconsistent associations with brain aging using cognitive change as an outcome (and not neuroimaging or clinical dementia or Alzheimer’s disease diagnosis). However, blood carotenoids levels were associated with lower risk of dementia over 10 years, in a large cohort of older adults, the Three‐City (3C) study. Here, we further investigated whether blood carotenoids were also associated with the 10‐year atrophy of the medial temporal lobe (MTL), a central biomarker of neurodegeneration in aging. Method We included 461 dementia‐free participants from the 3C study (age ≥65), who had plasma carotenoid (α and β‐carotene, lycopene, lutein, zeaxanthin, β‐cryptoxanthin) measures at baseline and who underwent at least one of the three repeated brain imaging exams performed in the subsequent 10 years. Linear mixed models were used to assess the association between plasma carotenoids and MTL volume change assessed using FreeSurfer 5.1 segmentation software. Result Over a median follow‐up of 5.1 years (maximum 11.8 years), higher plasma levels of total carotenoids and of β‐carotene were associated with lower decline in MTL volume ( P = .04 and P = .008, respectively). The mean differences in MTL volume change for each increase of 1 SD were 0.02 (95% CI, 0.001; 0.04) cm 3 /year and 0.02 (0.01; 0.04) cm 3 /year for total carotenoids and β‐carotene, respectively. Other carotenoids were not significantly associated with MTL atrophy. Conclusion The associations found between plasma total carotenoids and β‐carotene and 10‐year atrophy of the MTL in this large cohort of older adults suggest a beneficial role of carotenoids for the prevention of age‐related neurodegeneration.
    Type of Medium: Online Resource
    ISSN: 1552-5260 , 1552-5279
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2020
    detail.hit.zdb_id: 2201940-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...